A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage

Trial Profile

A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage

Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2015

At a glance

  • Drugs Silodosin (Primary)
  • Indications Ureteral calculi
  • Focus Therapeutic Use
  • Sponsors Actavis Inc
  • Most Recent Events

    • 09 May 2014 New trial record
    • 08 Aug 2013
    • 05 Jul 2012
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top